Founded
Address
Alta Partners LP
One Embarcadero Center
37th Floor
San Francisco, CA 94111
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30601
Corporate information
Registration country
Company type
Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies.Funds managed
| Fund | Type | Vintage | Currency | Committed capital | IRR | x |
|---|---|---|---|---|---|---|
| Alta Partners VIII | Venture | 2006 | USD | 500,000,000 | ||
| Alta California Partners IV | Venture | 2004 | USD | 185,000,000 | ||
| Alta BioPharma Partners III LP | Venture | 2003 | USD | 302,000,000 | ||
| Alta BioPharma Partners II LP | Venture | 2000 | USD | 220,000,000 | 3.50 % | 1.20 x |
| Alta California Partners III LP | Venture | 2000 | USD | 237,000,000 | ||
| Alta California Partners II LP | Venture | 1999 | USD | 251,000,000 | ||
| Alta BioPharma Partners LP | Venture | 1998 | USD | 171,000,000 | ||
| Alta California Partners LP | Venture | 1996 | USD | 185,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 152| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Adolor Corp | N/A | ||||
|
|
AFx Inc | N/A | ||||
|
|
Angiosyn Inc | N/A | ||||
|
|
Arete Therapeutics Inc | A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. | Series A | |||
|
|
Arrow Therapeutics Ltd | N/A | ||||
|
|
Astex Pharmaceuticals Inc | Drug discovery, development and commercialization. | N/A | |||
|
|
Astex Therapeutics Ltd | N/A | ||||
|
|
Azelon Pharmaceuticals Inc | N/A | ||||
|
|
Be Inc | N/A | ||||
|
|
Bioventus LLC | Leading orthopedic biologics company | N/A | |||
|
|
Blaze Software Inc | N/A | ||||
|
|
Calistoga Pharmaceuticals Inc | Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases. | N/A | |||
|
|
Cara Therapeutics Inc | N/A | ||||
|
|
Carbylan BioSurgery Inc | N/A | ||||
|
|
Celetronix USA | N/A | ||||
|
|
Cellective Therapeutics Inc | N/A | ||||
|
|
Cellomics Inc | N/A | ||||
|
|
Ceregene Inc | Biotechnology company focused on the development and commercialization of gene therapies for the treatment of neurological disorders. | N/A | |||
|
|
Cerenis Therapeutics SA | N/A | ||||
|
|
Chemgenex Pharmaceuticals Ltd | N/A | ||||
|
|
ChemoCentryx Inc | N/A | ||||
|
|
Chimerix Inc | Series F | ||||
|
|
Chimerix Inc | Series E | ||||
|
|
Coloma Wireless | N/A | ||||
|
|
Connetics Corp | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Dan Janney | [email protected] |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Garrett Gruener (founder) | Nanomix Inc | |||
| Ed Hurwitz | Precision Bioventures LLC | |||
| Robert Simon | Saints Capital LLC | |||
| Katya Smirnyagina | Capricorn Partners | |||
| Hilary Strain | Wing Ventures |